Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 78.50% is in line with its 5-year average of 84.96%, near the high end of its 5-year range (-2266.67%–362.81%).
120.27% above its 12-month average of -387.31%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 60.00%.
GROSS MARGIN
78.50%
GROSS MARGIN AVG TTM
-387.31%
GROSS MARGIN AVG 3Y
76.40%
GROSS MARGIN AVG 5Y
84.96%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+120.27%
CURRENT VS 3Y AVG
+2.75%
CURRENT VS 5Y AVG
-7.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
+82.94%
vs the sector median at left
Market Cap
$50.25M
Gross Margin
-262.66%
TTM Avg
-246.22%
3Y Avg
-188.06%
5Y Avg
-150.05%
Market Cap
$51.12M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$52.95M
Gross Margin
N/A
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
16.67%
Market Cap
$53.01M
Gross Margin
-29.12%
TTM Avg
13.64%
3Y Avg
-48.92%
5Y Avg
-105.92%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | $49.96M | 78.50% | -387.31% | 76.40% | 84.96% |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -262.66% | -246.22% | -188.06% | -150.05% |
| Celularity Inc. (CELU)vs › | $49.50M | 79.62% | 74.20% | 42.17% | 48.15% |
| Apollomics, Inc. (APLM)vs › | $50.51M | 97.00% | 98.50% | 99.25% | 99.50% |
| biote Corp. (BTMD)vs › | $49.40M | 71.46% | 70.99% | 69.42% | 67.35% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | N/A | 50.00% | 25.00% | 16.67% |
| ImageneBio Inc (IMA)vs › | $53.01M | -29.12% | 13.64% | -48.92% | -105.92% |
| BioStem Technologies, Inc. (BSEM)vs › | $46.79M | 93.13% | 94.29% | 92.05% | 80.64% |
Gross Margin
78.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 60.00% |
| 2026-03-31 | -2266.67% |
| 2025-12-31 | 70.13% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 75.31% |
| 2024-12-31 | 80.22% |
| 2024-09-30 | 79.31% |
| 2024-06-30 | 80.22% |
| 2024-03-31 | 78.08% |
| 2023-12-31 | -170.59% |
| 2023-09-30 | 88.89% |
| 2023-06-30 | 75.46% |
| 2023-03-31 | 95.33% |
| 2022-12-31 | -77.35% |
| 2022-09-30 | 89.08% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | 362.81% |
| 2021-09-30 | 87.27% |
| 2021-06-30 | -176.12% |
| 2021-03-31 | -14.08% |
| 2020-12-31 | 75.86% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 17.14% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
